Article Text

Download PDFPDF
9 IgG anti-malonedialdehyde-LDL antibodies are associated with low risk of cardiovascular events in a substudy of the anglo-scandinavian cardiac outcomes trial (Ascot), and are unrelated To LDL, CRP levels and statin treatment
  1. R Y Khamis1,
  2. M Johns1,
  3. S Thom2,
  4. J Mayet2,
  5. E McConnell1,
  6. A Stanton3,
  7. S Jeyapalan1,
  8. S Annon1,
  9. S Wrigley1,
  10. A Hughes2,
  11. D O Haskard1
  1. 1Vascular Sciences Section, NHLI, Imperial College, London, UK
  2. 2International Centre for Circulatory Health, NHLI, Imperial College London, UK
  3. 3Department of Clinical Pharmacology Royal College of Surgeons of Ireland, Dublin

Abstract

Background We aimed to determine whether measurement of antibodies to modified LDL predicts cardiovascular events.

Methods We studied ASCOT participants without diabetes with total cholesterol of ≤6.5 mmol/l and a total cholesterol/HDL ratio ≤4.5. IgG and IgM antibodies against malondialdehyde-modified LDL (MDA-LDL) and phosphorylcholine (PC) were measured by ELISA at baseline and after one year on atorvastatin (10 mg daily; n=100) or placebo (n=100). CRP, carotid intima-media thickness (CIMT), Framingham 10-year CVD Risk score (FRS) and total and LDL cholesterol (LDL) were determined.

Results Antibody levels did not correlate with baseline LDL, or LDL, CRP or CIMT at 1 year. Atorvastatin reduced LDL by 1.44 mmol/l (p<0.001, 95% CI 1.31 to 1.58 adjusted for age and sex), but did not influence IgG or IgM antibodies against MDA-LDL (p=0.74 and p=0.38) or PC (p=0.26 and p=−0.556). However, following adjustment for classical risk factors, baseline IgG anti-MDA-LDL levels predicted protection from cardiovascular events (HR=0.22, 95% CI 0.052 to 0.92; p=0.04). There was also a trend for IgG anti-MDA-LDL being protective after adjustment for FRS, (HR=0.33, 95% CI 0.089 to 1.20; p=0.09).

Conclusion IgG anti- MDA-LDL antibody levels are unrelated to LDL cholesterol levels, CRP, CIMT, and are not affected by treatment with atorvastatin. However, elevated levels are associated with significant protection against cardiovascular events and may be useful in clinical risk stratification for cardiovascular disease.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.